Morgan Stanley initiated coverage on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a research note published on Monday morning, MarketBeat.com reports. The firm issued an overweight rating and a $27.00 price objective on the stock.
ARDT has been the topic of several other research reports. SVB Leerink started coverage on shares of Ardent Health Partners in a report on Monday. They issued an outperform rating and a $23.00 price target on the stock. Truist Financial started coverage on shares of Ardent Health Partners in a report on Monday. They issued a buy rating and a $21.00 price target on the stock. JPMorgan Chase & Co. started coverage on shares of Ardent Health Partners in a report on Monday. They issued a neutral rating and a $18.00 price target on the stock. Finally, Mizuho started coverage on shares of Ardent Health Partners in a research report on Monday. They issued an outperform rating and a $20.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of Buy and a consensus price target of $21.70.
Check Out Our Latest Stock Analysis on Ardent Health Partners
Ardent Health Partners Trading Up 0.2 %
Ardent Health Partners Company Profile
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Read More
- Five stocks we like better than Ardent Health Partners
- Ride Out The Recession With These Dividend Kings
- Brinker International’s Price Dip is an Appetizing Entry Point
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stocks That Could Beat the September Blues
- Using the MarketBeat Stock Split Calculator
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.